Proposed Budget Includes CBD Research and Regulations.
Bloomberg Law reports that the President’s proposed budget may accelerate long-awaited FDA CBD regulation, as federal agencies respond to growing demand for oversight of cannabis-derived products. The proposal highlights cannabis regulation as a priority and includes funding for research, inspections, and enforcement actions targeting improperly marketed CBD products.
FDA CBD Regulations May Advance Under Proposed Budget
Bloomberg Law reports that the President’s proposed budget may finally accelerate long-awaited FDA CBD regulation, as federal agencies face increasing pressure to address the rapid growth of cannabis-derived products.
“Cannabis regulation is a new top-line priority for the FDA as Congress demands better research and the cannabis-derived supplement CBD grows in popularity, according to President Donald Trump’s budget proposal released Monday.
The administration’s budget request carves out $5 million for the Food and Drug Administration to conduct research and inspections and crack down on illegally marketed cannabis products.”
For more details, refer to the Bloomberg Law report on FDA CBD regulation developments.